Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00610558 · ClinicalTrials.gov registry record · NA

Neocortical Epilepsies - Do They Progress?

A NA study, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00610558: Completed NA study, sponsored by University of California, Irvine.

NCT00610558 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00610558, a NA study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.

Primary Outcome

We will analyze the structural and metabolic differences between two epilepsy groups (JME and FLE) and understand the imaging presentations of epilepsy patients. We will process imaging requisition for Arm 1 and Arm 2 patients and the controls to examine if any differences in their brain image. The hypothesis is the functional connectivity between brainstem structures and cortical/subcortical regions may reflect in their imaging data. We would like to know if these imaging factors are related to

Interventions

  • DEVICE Arm 1: Juvenile Myoclonic Epilepsy
  • DEVICE Arm 2: Frontal Lobe Epilepsy
  • DEVICE Arm 3: Normal Controls

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2003-07
Est. Completion 2010-09
Phase NA
University of California, Irvine

368 total trials

What the finished NCT00610558 record still lists

NCT00610558 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which Arm 1: Juvenile Myoclonic Epilepsy is the first listed.

NCT00610558 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00610558 about?

NCT00610558 is a clinical study titled "Neocortical Epilepsies - Do They Progress?". This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.

What is the current status of trial NCT00610558?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2003-07. Estimated completion is 2010-09.

What interventions are being tested in trial NCT00610558?

The interventions under investigation include: Arm 1: Juvenile Myoclonic Epilepsy (DEVICE), Arm 2: Frontal Lobe Epilepsy (DEVICE), Arm 3: Normal Controls (DEVICE).

Who is sponsoring clinical trial NCT00610558?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00610558's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00610558, the US trial registry maintained by the National Library of Medicine. NCT00610558 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.